A vaccine against Asian schistosomiasis

Parasitology International

Volumn 53, Issue 2, 2004, Pages 163-173

  McManus, Donald P ^a   Bartley, Paul B ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Paramyosin; Schistosoma japonicum; Transmission blocking vaccine; Vaccine

Indexed keywords

DNA VACCINE; PARAMYOSIN; PRAZIQUANTEL; RECOMBINANT ASPARTIC PROTEASE; RECOMBINANT CALPAIN LARGE SUBUNIT; RECOMBINANT GLUTATHIONE S TRANSFERASE; RECOMBINANT INTEGRAL MEMBRANE PROTEIN; RECOMBINANT PARAMYOSIN; RECOMBINANT TRIOSE PHOSPHATE ISOMERASE; RECOMBINANT TRIOSEPHOSPHATE ISOMERASE; SCHISTOSOMA VACCINE; UNCLASSIFIED DRUG;

CANCER CHEMOTHERAPY; CHINA; DISEASE TRANSMISSION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG TARGETING; HUMAN; IMMUNITY; NONHUMAN; PHILIPPINES; PRIORITY JOURNAL; REVIEW; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS;

ANIMALS; ANTIGENS, HELMINTH; ASIA; HUMANS; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; VACCINES;

JAPONICA; SCHISTOSOMA; SCHISTOSOMA JAPONICUM;

EID: 1842785761     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parint.2004.01.006     Document Type: Review

References (74)

1. van der Werf M.J., de Vlas S.J., Brooker S., Looman C.W., Nagelkerke N.J., Habbema J.D., Engels D. Acta Trop. 86:2003;125-139.
2. Ross A.G., Bartley P.B., Sleigh A.C., Olds G.R., Li Y., Williams G.M., McManus D.P. Schistosomiasis. N Engl J Med. 346:2002;1212-1220.
3. Ross A.G., Sleigh A.C., Li Y., Davis G.M., Williams G.M., Jiang Z., Feng Z., McManus D.P. Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century. Clin Microbiol Rev. 14:2001;270-295.
4. Bergquist R., Colley D. Schistosomiasis vaccines: research to development. Parasitol Today. 14:1998;99-104.
5. Ismail M., Metwally A., Farghaly A., Bruce J., Tao L., Bennett J. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. Am J Trop Med Hyg. 55:1996;214-218.
6. Fallon P., Sturrock R., Niang A., Doenhoff M. Short report: diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni. Am J Trop Med Hyg. 53:1995;61-62.
7. Stelma F.F., Talla I., Sow S., Kongs A., Niang M., Polman K., Deelder A.M., Gryseels B. Efficacy and side effects of praziquantel in an endemic focus of Schistosoma mansoni. Am J Trop Med Hyg. 53:1995;167-170.
8. Todd C., Colley D. Practical and ethical issues in the development of a vaccine against schistosomiasis mansoni. Am J Trop Med Hyg. 66:2002;348-358.
9. Capron A., Riveau G., Bartley P., McManus D.P. Prospects for a schistosome vaccine. Curr Drug Targets Immune Endocr Metab Disord. 2:2002;281-290.
10. Riveau G., Capron A. Vaccination against schistosomiasis: concepts and strategies. Kaufmann S. Concepts in vaccine design. 1996;509-532 Walter de Gruyter, Berlin, New York.
11. Riveau G., Capron A. Vaccines against schistosomiasis. Levine M.M. New generation vaccines. 1996;1081-1093 Marcel Dekker, New York.
12. McManus D.P. The search for a vaccine against schistosomiasis - a difficult path but an acjhievable goal. Immunol Rev. 171:1999;149-161.
13. Capron A., Dessaint J.P., Capron M., Bazin H. Specific IgE antibodies in immune adherence of normal macrophages to Schistosoma mansoni schistosomules. Nature. 253:1975;474-475.
14. Capron M., Bazin H., Joseph M., Capron A. Evidence for IgE-dependent cytotoxicity by rat eosinophils. J Immunol. 126:1981;1764-1768.
15. Capron M., Capron A. Rats, mice and men. Models for immune effector mechanisms against schistosomiasis. Parasitol Today. 2:1986;69-75.
16. Ross A.G.P., Sleigh A.C., Li Y.S., Williams G.M., Aligui G.D.L., McManus D.P. Is there immunity to Schistosoma japonicum? Parasitol Today. 16:2000;159-164.
17. Hagan P., Blumenthal U.J., Dunn D., Simpson A.J.G., Wilkins H.A. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature. 349:1991;243-245.
18. Demeure C.E., Rihet P., Abel L., Ouattara M., Bourgeois A., Dessein A.J. Resistance to S. mansoni in humans:influence of IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. J Infect Dis. 168:1993;1000-1008.
19. Grezel D., Capron M., Grzych J., Fontaine J., Lecocq J., Capron A. Protective immunity induced in rat schistosomiasis by a single dose of the Sm28GST recombinant antigen: effector mechanisms involving IgE and IgA antibodies. Eur J Immunol. 23:1993;454-460.
20. Grzych J.M., Grezel D., Xu C.B., Neyrinck J.L., Capron M., Ouma J.H., et al. IgA antibodies to a protective antigen in human schistosomiasis mansoni. J Immunol. 150:1993;527-635.
21. Grzych J.M., De Bont J., Neyrinck J.L., Fontaine J., Vercruysse J., Capron A. Relationship of impairment of schistosome 28-kilodalton glutathione S-transferase (GST) activity to expression of immunity to Schistosoma mattheei in calves vaccinated with recombinant Schistosoma bovis 28-kilodalton GST. Infect Immun. 66:1998;1142-1148.
22. Pearce E., MacDonald A. The immunobiology of schistosomiasis. Nature Rev Immunol. 2:2002;499-511.
23. Acosta L., Waine G., Aligui G., Tiu W.U., Olveda R., McManus D.P. Immune correlate study on human Schistosoma japonicum in a well-defined population in Leyte, Philippines: II. Cellular immune responses to S. japonicum recombinant and native antigens. Acta Trop. 84:2002;137-149.
24. Chitsulo L., Engels D., Montresor A., Savioli L. The global status of schistosomiasis and its control. Acta Trop. 77:2000;41-51.
25. Morel C. Reaching maturity-25 years of the TDR. Parasitol Today. 16:2000;522-529.
26. Li Y., Sleigh A.C., Ross A.G., Li Y., Zhang X., Williams G.M., Yu X., Tanner M., McManus D.P. Human susceptibility to Schistosoma japonicum in China correlates with antibody isotypes to native antigens. Trans R Soc Trop Med Hyg. 95:2001;441-448.
27. McManus D.P., Ross A.G., Sleigh A.C., Williams G.M., Yang W., Li Y.S., Li Y., Acosta L., Waine G.J. Production of interleukin-10 by peripheral blood mononuclear cells from residents of a marshland area in China endemic for Schistosoma japonicum. Parasitol Int. 48:1999;169-177.
28. Le T., Humair P., Blair D., Agatsuma T., Littlewood D., McManus D.P. Mitochondrial gene content, arrangement and composition compared in African and Asian schistosomes. Mol Biochem Parasitol. 117:2001;61-71.
29. Zhang Y., Taylor M., Bickle Q., Wang H., Ge J. Vaccination of mice with gamma-irradiated Schistosoma japonicum cercariae. Parasite Immunol. 21:1999;111-117.
30. Loukas A., Jones M., King L., Brindley P.J., McManus D.P. Receptor for Fc on the surfaces of schistosomes. Infect Immun. 69:2001;3646-3651.
31. McManus D.P., Wong J.Y., Zhou J., Cai C., Zeng Q., Smyth D., Li Y., Kalinna B.H., Duke M.J., Yi X. Recombinant paramyosin (rec-Sj-97) tested for immunogenicity and vaccine efficacy against Schistosoma japonicum in mice and water buffaloes. Vaccine. 12:2001;870-878.
32. Williams G.M., Sleigh A.C., Li Y., Feng Z., Davis G.M., Chen H., Ross A.G., Bergquist R., McManus D.P. Mathematical modelling of schistosomiasis japonica: comparison of control strategies in the People's Republic of China. Acta Trop. 82:2002;253-262.
33. Zhang R., Suzuki T., Takahashi S., Yoshida A., Kawaguchi H., Maruyama H., Yabu Y., Fu J., Shirai T., Ohta N. Cloning and molecular characterization of calpain, a calcium-activated neutral proteinase, from different strains of Schistosoma japonicum. Parasitol Int. 48:2000;232-242.
34. Zhang R., Yoshida A., Kumagai T., Kawaguchi H., Maruyama H., Suzuki T., Itoh M., El-Malky M., Ohta N. Vaccination with calpain induces a Th1-biased protective immune response against Schistosoma japonicum. Infect Immun. 69:2001;386-391.
35. Li Y., Auliff A., Jones M., Yi X., McManus D.P. Immunogenicity and immunolocalization of the 22.6 kDa antigen of Schistosoma japonicum. Parasite Immunol. 22:2000;415-424.
36. Verity C., McManus D.P., Brindley P.J. Vaccine efficacy of recombinant cathepsin D aspartic protease from Schistosoma japonicum. Parasite Immunol. 23:2001;153-162.
37. Liu S.X., Song G.C., Xu Y.X., Yang W., McManus D.P. Immunization of mice with recombinant Sjc26GST induces a pronounced anti-fecundity effect after experimental infection with Chinese Schistosoma japonicum. Vaccine. 13:1995;603-607.
38. Liu S.X., Song G., Xu Y., Yang W., McManus D.P. Anti-fecundity immunity induced in pigs vaccinated with recombinant Schistosoma japonicum 26 kDa glutathione-S-transferase. Parasite Immunol. 17:1995;340-355.
39. Liu S.X., Yongkang H., Guangchen S., Xing-song L., Yuxin X., McManus D.P. Anti-fecundity immunity to Schistosoma japonicum induced in Chinese water buffaloes (Bos buffelus) after vaccination with recombinant 26 kDa glutathione-S-transferase (reSjc26GST). Vet Parasitol. 69:1997;39-47.
40. Verity C., McManus D.P., Brindley P.J. Developmental expression of cathepsin D aspartic protease in Schistosoma japonicum. Int J Parasitol. 29:1999;1819-1824.
41. Verity C., McManus D.P., Brindley P.J. Cellular responses to Schistosoma japonicum cathepsin D aspartic protease. Parasite Immunol. 24:2002;363-367.
42. Taylor M.G., Huggins M.C., Shi F., Lin J., Tian E., Ye P., Shen W., Qian C.G., Lin B.F., Bickle Q.D. Production and testing of Schistosoma japonicum candidate vaccine antigens in the natural ovine host. Vaccine. 16:1998;1290-1298.
43. Gurunathan S., Klinman D., Seder R. DNA vaccines: immunology, application and optimization. Annu Rev Immunol. 18:2000;927-974.
44. Alarcon J., Waine G., McManus D.P. DNA vaccines: technology and application as anti-parasite and anti-microbial agents. Adv Parasitol. 42:1999;343-410.
45. Kofta W., Wedrychowicz H. c-DNA vaccination against parasitic infections: advantages and disadvantages. Vet Parasitol. 100:2001;3-12.
46. Rosas G., Fragoso G., Garate T., Hernandez B., Ferrero P., Foster-Cuevas M., Parkhouse R.M., Harrison L.J., Briones S.L., Gonzalez L.M., Sciutto E. Protective immunity against Taenia crassiceps murine cysticercosis induced by DNA vaccination with a Taenia saginata tegument antigen. Microbes Infect. 4:2002;1417-1426.
47. Wang Q., Sun S., Hu Z., Wu D., Wang Z. Immune response and protection elicited by DNA immunisation against Taenia cysticercosis. Vaccine. 21:2003;1672-1680.
48. Cai X., Chai Z., Jing Z., Wang P., Luo X., Chen J., Dou Y., Feng S., Su C., Jin J. Studies on the development of DNA vaccine against Cysticercus cellulosae infection and its efficacy. Southeast Asian J Trop Med Public Health. 32:2001;105-110.
49. Mantoucharian K., Terrazas L., Gevorkian G., Govezensky T. Protection against murine cysticercosis using cDNA expression library immunization. Immunol Lett. 62:1998;131-136.
50. Kofta W., Mieszczanek J., Plucienniczak G., Wedrychowicz H. Successful DNA vaccination of rats against fasciolosis. Vaccine. 18:2000;2985-2990.
51. Harrison R., Wu Y., Egerton G., Bianco A. DNA immunization with Onchocerca volvulus chitinase induces partial protection against challenge infection with L3 larvae in mice. Vaccine. 18:1999;647-655.
52. Waine G., Alarcon J., McManus D.P. Genetic immunization of mice with DNA encoding the 23 kDa transmembrane surface protein of Schistosoma japonicum (Sj23) induces antigen-specific immunoglobulin G antibodies. Parasite Immunol. 21:1999;377-381.
53. Waine G., Mazzer D., McManus D.P. DNA immunization by intramuscular injection or gene gun induces specific IgG antibodies against a Schistosoma japonicum 22 kDa antigen, Sj22, when fused to the murine Ig K-chain secretory leader sequence. Parasite Immunol. 21:1999;53-56.
54. Waine G., Yang W., Scott J., McManus D.P., Kalinna B. DNA-based vaccination using Schistosoma japonicum (Asian blood-fluke) genes. Vaccine. 15:1997;846-848.
55. Siddiqui A.A., Phillips T., Charest H., Podesta R.B., Quinlin M.L., Pinkston J.R., Lloyd J.D., Pompa J., Villalovos R.M., Paz M. Enhancement of Sm-p80 (large subunit of calpain) induced protective immunity against Schistosoma mansoni through co-delivery of interleukin-2 and interleukin-12 in a DNA vaccine formulation. Vaccine. 21:2003;2882-2889.
56. Zhang Y., Taylor M., Johansen M., Bickle Q. Vaccination of mice with a cocktail DNA vaccine induces a Th1-type immune response and partial protection against Schistosoma japonicum infection. Vaccine. 20:2001;724-730.
57. Shi F., Zhang Y., Lin J., Zuo X., Shen W., Cai Y., Ye P., Bickle Q.D., Taylor M.G. Field testing of Schistosoma japonicum DNA vaccines in cattle in China. Vaccine. 20:2002;3629-3631.
58. Shi F., Zhang Y., Ye P., et al. Laboratory and field evaluation of Schistosoma japonicum DNA vaccines in sheep and water buffalo in China. Vaccine. 20:2001;462-467.
59. Zeng X, Yi X, Zeng X, Zhou J. [Experimental study on immunization of mice with nucleic acid vaccine Sj31BIN combining IL-12 against Schistosoma japonicum]. Hunan Yi Ke Da Xue Xue Bao, 2000;25: 334-336.
60. Feng X, Lin J, Zhu J, Zhang L, Yuan C, Cai Y. [Protective effect induced by vaccination with a partial cDNA expression library of Schistosoma japonicum in mice]. Sheng Wu Gong Cheng Xue Bao, 2002;18: 231-234.
61. Gilbert S.C., Schneider J., Hannan C.M., Hu J.T., Plebanski M., Sinden R., Hill A.V. Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes. Vaccine. 20:2002;1039-1045.
62. Degano P., Schneider J., Hannan C., Gilbert S., Hill A. Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+T cell immunogenicity and protective efficacy in the influenza and malaria models. Vaccine. 18:1999;623-632.
63. Jones T.R., Narum D.L., Gozalo A.S., Aguiar J., Fuhrmann S.R., Liang H., Haynes J.D., Moch J.K., Lucas C., Luu T., Magill A.J., Hoffman S.L., Sim B.K. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen. J Infect Dis. 183:2001;303-312.
64. Hall R., Adamson R., Boulter N. Prime-boost: the way forward for recombinant vaccines against apicomplexan parasites. A Theileria perspective. Parasitol Res. 88:2002;S45-S47.
65. Flanigan T., King C., Lett R., Nanduri J., Mahmoud A. Induction of resistance to Schistosoma mansoni infection in mice by purified parasite paramyosin. J Clin Invest. 83:1989;1010-1014.
66. Zhou S., Liu S., Song G., Xu Y., Sun W. Protective immunity induced by the full-length cDNA encoding paramyosin of Chinese Schistosoma japonicum. Vaccine. 18:2000;3196-3204.
67. Smyth D., McManus D.P., Smout M., Laha T., Zhang W., Loukas A. Isolation of cDNAs encoding secreted and transmembrane proteins from Schistosoma mansoni by a signal sequence trap method. Infect Immun. 71:2003;2548-2554.
68. Woollard D., Gauci C., Heath D., Lightowlers M. Protection against hydatid disease induced with the EG95 vaccine is associated with conformational epitopes. Vaccine. 19:2000;498-507.
69. Okano M., Satoskar A., Nishizaki K., Harn D.J. Lacto-N-fucopentose III found on Schistosoma mansoni egg antigens functions as adjuvant for proteins by inducing Th2-type response. J Immunol. 167:2001;442-450.
70. Hu W., Yan Q., Shen D.K., Liu F., Zhu Z.D., Song H.D., Xu X.R., Wang Z.J., Rong Y.P., Zeng L.C., Wu J., Zhang X., Wang J.J., Xu X.N., Wang S.Y., Fu G., Zhang X.L., Wang Z.Q., Brindley P.J., McManus D.P., Xue C.L., Feng Z., Chen Z., Han Z.G. Evolutionary and biomedical implications of a Schistosoma japonicum complementary DNA resource. Nat Genet. 35:2003;139-147.
71. Feng Z. Functional genomics of Schistosoma japonicum. Parasitol Int, 2003; In Press.
72. Pearce E. Progress towards a vaccine for schistosomiasis. Acta Trop. 86:2003;309-313.
73. Colley D.G., LoVerde P.T., Savioli L. Medical helminthology in the 21st century. Science. 293:2001;1437-1438.
74. Verjovski-Almeida S., DeMarco R., Martins E.A., Guimaraes P.E., Ojopi E.P., Paquola A.C., Piazza J.P., Nishiyama M.Y. Jr, Kitajima J.P., Adamson R.E., Ashton P.D., Bonaldo M.F., Coulson P.S., Dillon G.P., Farias L.P., Gregorio S.P., Ho P.L., Leite R.A., Malaquias L.C., Marques R.C., Miyasato P.A., Nascimento A.L., Ohlweiler F.P., Reis E.M., Ribeiro M.A., Sa R.G., Stukart G.C., Soares M.B., Gargioni C., Kawano T., Rodrigues V., Madeira A.M., Wilson R.A., Menck C.F., Setubal J.C., Leite L.C., Dias-Neto E. Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni. Nat Genet. 35:2003;148-157.